Hematology/Oncology

Top Story

Genetic testing has increased in young women with breast cancer

Genetic testing has increased in young women with breast cancer
February 12, 2016

Read the Perspective from Kathryn Evers, MD

Most young women with breast cancer appear to undergo genetic testing for mutations in the BRCA1 and BRCA2 genes, according to results of a cross-sectional analysis of study data.

These data indicate that most women are following National Comprehensive Cancer Network guidelines that suggest women aged younger than 50 years when diagnosed with breast cancer undergo genetic testing.

In the Journals

Self-reported Agent Orange exposure higher among veterans with thyroid cancer

February 11, 2016
Self-reported Agent Orange exposure was more prevalent among patients with thyroid cancer compared with the overall national Veterans Affairs patient population, study…
In the Journals

Radiology guidelines have reduced variability in lung cancer screening strategies

February 11, 2016
Most leading U.S. academic medical centers use the same radiology guidelines and nodule threshold criteria within their lung cancer screening practices since the…
Meeting News Coverage

Top Takeaways from ASH: ELOQUENT-2 trial results of elotuzumab demonstrate immune effects

February 11, 2016
Updated results of the ELOQUENT-2 trial – a phase 3, randomized, open-label study – presented at the ASH Annual Meeting and Exposition focused on 3-year…
In the Journals

Hyperthyroidism increases breast cancer risk

February 11, 2016
Women with hyperthyroidism have an increased risk for breast cancer, whereas there was a slightly decreased risk among women with hypothyroidism, according to study…
More News Headlines »
CME

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty-five percent of lung cancers are non-small…
More »
Meeting News CoverageVideo

VIDEO: Negative ACCORD trial results reinforce standard of care for rectal cancer

January 27, 2016
More »
Featured
CME

World Lung Updates: Immunotherapy in NSCLC

This activity is supported by an educational grant from Genentech, Inc and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan
morganatic-roan